1. Home
  2. IMNN vs TSBX Comparison

IMNN vs TSBX Comparison

Compare IMNN & TSBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNN
  • TSBX
  • Stock Information
  • Founded
  • IMNN 1982
  • TSBX 2015
  • Country
  • IMNN United States
  • TSBX United States
  • Employees
  • IMNN N/A
  • TSBX N/A
  • Industry
  • IMNN Biotechnology: Pharmaceutical Preparations
  • TSBX
  • Sector
  • IMNN Health Care
  • TSBX
  • Exchange
  • IMNN Nasdaq
  • TSBX Nasdaq
  • Market Cap
  • IMNN 13.6M
  • TSBX 8.4M
  • IPO Year
  • IMNN 1985
  • TSBX 2023
  • Fundamental
  • Price
  • IMNN $0.88
  • TSBX $0.37
  • Analyst Decision
  • IMNN Strong Buy
  • TSBX Buy
  • Analyst Count
  • IMNN 2
  • TSBX 3
  • Target Price
  • IMNN $20.50
  • TSBX $4.75
  • AVG Volume (30 Days)
  • IMNN 141.9K
  • TSBX 173.1K
  • Earning Date
  • IMNN 05-12-2025
  • TSBX 03-24-2025
  • Dividend Yield
  • IMNN N/A
  • TSBX N/A
  • EPS Growth
  • IMNN N/A
  • TSBX N/A
  • EPS
  • IMNN N/A
  • TSBX N/A
  • Revenue
  • IMNN N/A
  • TSBX N/A
  • Revenue This Year
  • IMNN N/A
  • TSBX N/A
  • Revenue Next Year
  • IMNN N/A
  • TSBX N/A
  • P/E Ratio
  • IMNN N/A
  • TSBX N/A
  • Revenue Growth
  • IMNN N/A
  • TSBX N/A
  • 52 Week Low
  • IMNN $0.64
  • TSBX $0.34
  • 52 Week High
  • IMNN $3.65
  • TSBX $3.88
  • Technical
  • Relative Strength Index (RSI)
  • IMNN 49.35
  • TSBX 45.29
  • Support Level
  • IMNN $0.86
  • TSBX $0.35
  • Resistance Level
  • IMNN $0.93
  • TSBX $0.41
  • Average True Range (ATR)
  • IMNN 0.05
  • TSBX 0.03
  • MACD
  • IMNN 0.00
  • TSBX 0.00
  • Stochastic Oscillator
  • IMNN 61.00
  • TSBX 38.10

About IMNN Imunon Inc.

Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

Share on Social Networks: